文献速递胃肠外科围术期管理与 ERAS

磁括约肌增强装置取出:手术管理与结局

Removing the magnetic sphincter augmentation device: operative management and outcomes.
PubMed 文献 · Surg Endosc · 2018-11-01

单中心回顾性研究纳入2009年3月至2017年9月取出的24例磁括约肌增强装置(MSA),取出率为5.5%。取出最常见原因为复发性GERD(54%)和吞咽困难(38%),取出后52%症状缓解、35%改善,无重大并发症。

要点

  • MSA取出率5.5%,主要原因为复发性GERD和吞咽困难。
  • 取出时38%发现并修补食管裂孔疝,88%经腹腔镜完成。
  • 取出后52%症状缓解、35%改善,无重大并发症。

核心结论

  • MSA取出必要时可通过微创方式完成,取出后可根据情况重复植入Linx或行胃底折叠术。
  • 因吞咽困难取出者可能无需额外抗反流手术。

研究设计与样本

  • 单中心回顾性研究,2009年3月至2017年9月共植入435例MSA装置,其中24例需取出(5.5%)。

主要发现

  • 取出原因:难治性吞咽困难1.8%(8/435)、复发性或持续性GERD 2.9%(13/435)、侵蚀0.5%(2/435)。
  • 植入至取出平均时间863天(范围119-1762天)。
  • 取出时手术发现:复发性或进展性食管裂孔疝38%、侵蚀8%、正常解剖46%。
  • 取出途径:开腹4%、腹腔镜88%、内镜联合腹腔镜8%。
  • 取出后处理:重复MSA 33%、胃底折叠术21%、胃切除术4%、无额外手术42%。

临床怎么用

  • MSA取出可优先选择腹腔镜微创方式。
  • 取出时应探查并修补合并的食管裂孔疝。
  • 因吞咽困难取出者可不附加抗反流手术,因GERD取出者可考虑重复MSA或胃底折叠术。

局限性

  • 单中心回顾性研究,样本量小(24例取出),随访时间短且不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recurrent or persistent symptoms of reflux, dysphagia, or device erosion can lead to removal of the magnetic sphincter augmentation (MSA aka Linx) device. Device removal has been previously reported, and outcomes of various surgical management strategies at the time of removal have not been well described. METHODS: This is a retrospective review of patients undergoing MSA removal from March 2009 to September 2017 in a single institution. Reason for removal, operative management, and short-term outcomes are reported. RESULTS: During the study, 435 MSA devices were implanted, 24 of which required removal (5.5%). Removal was due to refractory dysphagia in 1.8% (8/435), for recurrent or persistent GERD in 2.9% (13/435), and secondary to erosion in 0.5% (2/435). Mean time from implant to removal was 863 days (range 119-1762 days). The most common reasons for removal were recurrent GERD (54%), dysphagia (38%), or erosion (8%). Significant operative findings included recurrent or progressive hiatal hernia (38%), erosion (8%), and normal anatomy (46%). Hiatal hernia was found and repaired at the time of device removal in 38% of patients (9/24). The MSA device was removed through laparotomy (4%), laparoscopically (88%), or through a combination of endoscopy and laparoscopy (8%). After removal patients underwent repeat MSA (33%), fundoplication (21%), gastrectomy (4%), or no additional procedure (42%). Symptoms prompting removal of the MSA device had resolved in 52% of patients and improved in an additional 35% at last contact. Of the 10 patients having no anti-reflux procedure after removal, 9 were available for follow-up at a mean of 97 (106) days of whom 22.2% (2/9) had symptoms of GERD or required any anti-reflux medication. No major complications occurred after removal. CONCLUSION: MSA removal when necessary can be accomplished through minimally invasive means. Repeat Linx or fundoplication can be performed after removal, however may not be necessary in patients with removal for dysphagia.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Tatum JM, Alicuben E, Bildzukewicz N, et al. Removing the magnetic sphincter augmentation device: operative management and outcomes. Surg Endosc. 2018. PMID: 30386987. doi:10.1007/s00464-018-6544-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。